• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

化脓性汗腺炎恶变的致命结局:一例报告及文献复习

Fatal outcome of malignant transformation of hidradenitis suppurativa: A case report and literature review.

作者信息

Nielsen Valdemar Wendelboe, Jørgensen Astrid-Helene Ravn, Thomsen Simon Francis

机构信息

Department of Dermato-Venereology & Wound Healing Centre Bispebjerg Hospital Copenhagen Denmark.

Department of Biomedical Sciences University of Copenhagen Copenhagen Denmark.

出版信息

Clin Case Rep. 2020 Feb 6;8(3):504-507. doi: 10.1002/ccr3.2608. eCollection 2020 Mar.

DOI:10.1002/ccr3.2608
PMID:32185045
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7069843/
Abstract

Squamous cell carcinoma arising in hidradenitis suppurativa (HS) is a rare albeit the most serious complication in HS, with a reported fatality of up to 42.9%. This calls for greater clinical awareness in patients with long-standing chronic HS.

摘要

化脓性汗腺炎(HS)中发生的鳞状细胞癌是HS中一种罕见但最严重的并发症,据报道死亡率高达42.9%。这就要求对长期慢性HS患者提高临床认识。

相似文献

1
Fatal outcome of malignant transformation of hidradenitis suppurativa: A case report and literature review.化脓性汗腺炎恶变的致命结局:一例报告及文献复习
Clin Case Rep. 2020 Feb 6;8(3):504-507. doi: 10.1002/ccr3.2608. eCollection 2020 Mar.
2
Infiltrative squamous cell carcinoma in hidradenitis suppurativa: A case report for early surgical intervention.化脓性汗腺炎中的浸润性鳞状细胞癌:早期手术干预的病例报告
Int J Surg Case Rep. 2019;55:50-53. doi: 10.1016/j.ijscr.2019.01.006. Epub 2019 Jan 19.
3
A case of a patient with stage III familial hidradenitis suppurativa treated with 3 courses of infliximab and died of metastatic squamous cell carcinoma.1例III期家族性化脓性汗腺炎患者接受3个疗程英夫利昔单抗治疗后死于转移性鳞状细胞癌。
Dermatol Online J. 2014 Mar 17;20(3):doj_21764.
4
Three fatal cases of squamous cell carcinoma arising in chronic perineal hidradenitis suppurativa.3例慢性会阴化脓性汗腺炎继发鳞状细胞癌致死病例。
Ann R Coll Surg Engl. 2007 Oct;89(7):709-12. doi: 10.1308/003588407X209392.
5
Vulvar cancer in hidradenitis suppurativa.化脓性汗腺炎中的外阴癌
Gynecol Oncol Rep. 2022 Jan 17;39:100929. doi: 10.1016/j.gore.2022.100929. eCollection 2022 Feb.
6
Vulvar, Perianal and Perineal Cancer After Hidradenitis Suppurativa: A Systematic Review and Pooled Analysis.化脓性汗腺炎后外阴、肛周和会阴癌:一项系统评价与汇总分析
Dermatol Surg. 2017 Jan;43(1):107-115. doi: 10.1097/DSS.0000000000000944.
7
Cutaneous squamous cell carcinoma arising in hidradenitis suppurativa: A case report.发生于化脓性汗腺炎的皮肤鳞状细胞癌:一例报告。
SAGE Open Med Case Rep. 2019 May 17;7:2050313X19847359. doi: 10.1177/2050313X19847359. eCollection 2019.
8
Hidradenitis suppurativa complicated by squamous cell carcinoma.化脓性汗腺炎并发鳞状细胞癌。
Am Surg. 2008 Dec;74(12):1177-81.
9
Hidradenitis suppurativa and squamous cell carcinoma.化脓性汗腺炎与鳞状细胞癌。
Dermatol Surg. 2002 Jan;28(1):88-90. doi: 10.1046/j.1524-4725.2002.01090.x.
10
Vulval squamous cell carcinoma arising in chronic hidradenitis suppurativa.慢性化脓性汗腺炎伴发的外阴鳞状细胞癌。
Clin Exp Dermatol. 2005 Sep;30(5):481-3. doi: 10.1111/j.1365-2230.2005.01875.x.

引用本文的文献

1
A state-of-the-art systematic review of cancer in hidradenitis suppurativa.一项关于化脓性汗腺炎中癌症的最新系统评价。
Ann Med. 2024 Dec;56(1):2382372. doi: 10.1080/07853890.2024.2382372. Epub 2024 Jul 24.
2
Neoplastic Implications in Patients Suffering from Hidradenitis Suppurativa under Systemic Treatments.全身性治疗的化脓性汗腺炎患者的肿瘤学意义
Biomedicines. 2021 Nov 1;9(11):1594. doi: 10.3390/biomedicines9111594.
3
The Clinical Relevance of the Microbiome in Hidradenitis Suppurativa: A Systematic Review.化脓性汗腺炎中微生物组的临床相关性:一项系统综述。

本文引用的文献

1
Huge Squamous Cell Carcinoma Arising on Severe Hidradenitis Suppurativa.
Actas Dermosifiliogr (Engl Ed). 2018 Nov;109(9):828. doi: 10.1016/j.ad.2017.11.015. Epub 2018 Jul 30.
2
Squamous cell carcinoma of the perineum masquerading as necrotizing hidradenitis suppurativa.伪装成坏死性化脓性汗腺炎的会阴部鳞状细胞癌。
Dermatol Online J. 2018 Apr 15;24(4):13030/qt3pb602cq.
3
Cutaneous squamous cell carcinoma complicating hidradenitis suppurativa: a review of the prevalence, pathogenesis, and treatment of this dreaded complication.化脓性汗腺炎并发皮肤鳞状细胞癌:对这种可怕并发症的患病率、发病机制及治疗的综述
Vaccines (Basel). 2021 Sep 25;9(10):1076. doi: 10.3390/vaccines9101076.
4
Vulval squamous cell carcinoma arising from hidradenitis suppurrativa.由化脓性汗腺炎引起的外阴鳞状细胞癌。
BMJ Case Rep. 2021 Jun 15;14(6):e241075. doi: 10.1136/bcr-2020-241075.
Acta Dermatovenerol Alp Pannonica Adriat. 2018 Mar;27(1):25-28.
4
Non-surgical treatments for hidradenitis suppurativa: A systematic review.化脓性汗腺炎的非手术治疗:一项系统评价。
Ann Chir Plast Esthet. 2017 Aug;62(4):274-294. doi: 10.1016/j.anplas.2017.03.012. Epub 2017 Apr 28.
5
Rare "Inverted" Verrucous Carcinoma (Carcinoma Cuniculatum) of the Sacrogluteal Region: Case Report and Literature Review.罕见的骶臀区域“倒置”疣状癌(漏斗状癌):病例报告及文献综述
Int J Surg Pathol. 2017 Aug;25(5):438-442. doi: 10.1177/1066896917696753. Epub 2017 Feb 1.
6
Advanced squamous cell carcinoma of the axillae mimicking hidradenitis suppurativa.酷似化脓性汗腺炎的腋窝晚期鳞状细胞癌。
J Eur Acad Dermatol Venereol. 2017 Sep;31(9):e421-e423. doi: 10.1111/jdv.14235. Epub 2017 Apr 10.
7
Squamous cell carcinoma arising in chronic hidradenitis suppurativa: a lethal complication to be avoided.慢性化脓性汗腺炎中发生的鳞状细胞癌:一种应避免的致命并发症。
Acta Oncol. 2017 Mar;56(3):497-498. doi: 10.1080/0284186X.2017.1292047. Epub 2017 Feb 20.
8
Squamous cell carcinoma complicating a chronic lesion of hidradenitis suppurativa: a case report and review of the literature.鳞状细胞癌并发慢性化脓性汗腺炎:一例报告并文献复习
Int Wound J. 2017 Apr;14(2):435-438. doi: 10.1111/iwj.12671. Epub 2016 Sep 29.
9
Squamous cell carcinoma in the setting of chronic hidradenitis suppurativa; report of a patient and update of the literature.慢性化脓性汗腺炎背景下的鳞状细胞癌:1例患者报告及文献综述
Dermatol Online J. 2015 Apr 16;21(4):13030/qt9q9707dp.
10
Smoking, chronic wound healing, and implications for evidence-based practice.吸烟、慢性伤口愈合及对循证实践的启示
J Wound Ostomy Continence Nurs. 2014 Sep-Oct;41(5):415-23; quiz E1-2. doi: 10.1097/WON.0000000000000057.